the International unlicensed name
Is not present
the Dosage form
of the Tablet, film coated
One tablet contains
active agents: the cleaned micronized flavonoidny fraction consisting of diosmin of 90% – 450 mg and flavonoids in the form of hesperidin of 10% – 50 mg,
excipients: gelatin, magnesium stearate, cellulose microcrystalline, starch sodium glycollate, talc, glitserol, macrogoal 6000, methylhydroxypropyl cellulose, gland (III) oxide red E172, sodium lauryl sulfate, titan E171 dioxide, gland (III) oxide yellow E172
of the Tablet of an oval form, film coated salmoncolored color
Vasoprotectives. The drugs reducing permeability of capillaries. Bioflavonoids. Diosmin in a combination with other
drugs ATX C05CA53 Code Pharmacological Pharmacokinetics In Properties an organism drug biotransformirutsya to phenolic acids.
Детралекс® it is brought out of an organism generally through intestines. Kidneys remove 14% of the accepted dose. Elimination half-life (T1/2) makes 11 h.
of Detraleks® has venotoniziruyushchy and angioprotektorny effect. Reduces extensibility of veins, raises their tone and reduces venous stagnation, reduces permeability of capillaries and increases their resistance, improves microcirculation, improves a lymphatic drainage. At systematic use of Detraleksa® the reduction of expressiveness of clinical symptoms of chronic venous insufficiency of the lower extremities of the organic and functional nature and also a hemorrhoidal disease is noted.
– symptomatic treatment of venous and lymphatic insufficiency (weight in legs, pain, hypostases and spasms)
– the functional symptoms connected with bad attacks of hemorrhoids.
A route of administration and doses
the Recommended dose makes 2 tablets a day, 1 tablet in the middle of the day and 1 tablet in the evening during meal.
At a bad attack of hemorrhoids: 6 tablets a day in the first 4 days (on 2 tablets 3 times a day), then – on 4 tablets in the next 3 days (on 2 tablets 2 times a day).
Duration of a course of treatment is defined by the attending physician.
The average duration of treatment is 2–3 months.
– diarrhea, nausea, vomiting
– dizziness, a headache, a general malaise
– skin rash, an itching, a small tortoiseshell
of the Contraindication
– hypersensitivity to drug
– the lactation period
At bad attacks of hemorrhoids the use of Detraleksa® does not replace specific treatment of other diseases of anorectal area. Drug is appointed a short course. At inefficiency of the carried-out treatment it is necessary to perform additional examination and to correct therapy. When prescribing drug the patients with disturbances of venous blood circulation should inform them on need of protection from long stay in the sun, long standing standing, decrease in body weight and wearing the special stockings improving blood circulation.
In pilot studies of teratogenic effect it is not revealed.
So far about any side effects at use of drug for pregnant women it was not reported.
The feature of influence on ability to run the vehicle and potentially dangerous
Detraleks® mechanisms does not affect ability to run motor transport and potentially dangerous mechanisms.
of the Message about cases of overdose are absent.
Symptoms: strengthening of side effects
the Form of release and packing
On 15 tablets place in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 2 or 4 planimetric packs together with the instruction for medical use in the state and Russian languages place in a box of cardboard.
To Store storage conditions at a temperature not above 30 °C.
To store out of children’s reach!
A period of storage
not to use drug after the expiration date specified on packing.
Les Laboratoires Servier Industrie Producer (Le Laboratoir of Servye Indastri), France